Wednesday, Nov. 11, 2020
8 a.m.–5 p.m.
The understanding of cancer immunobiology has increased dramatically in recent years, leading to the successful development of novel immune-based treatment options to improve cancer patient outcomes. The SITC Primer on Tumor Immunology and Cancer Immunotherapy™ is designed to provide a foundation for understanding core immunology principles as they relate to basic and clinical research in immunotherapy of cancer. New this year, the Primer will also touch on emerging therapies and technologies to ensure attendees at all levels stay updated in our expanding field, while also laying a comprehensive foundational base for all SITC 2020 attendees.
8 a.m.–5 p.m.
CAR T treatments have led to improved outcomes for patients with hematologic malignancies. However, the same level of success has not been achieved in most solid tumors, and other immune cell types beyond T cells are also being explored preclinically and clinically. This workshop will therefore highlight the multitude of cellular therapy approaches being applied for the treatment of cancer, including many T cell strategies, alternative immune cells, practical considerations and novel technologies.
Throughout four didactic sessions led by experts in the field and participation in four engaging panel discussions, attendees will discuss a number of topics, including:
- CAR T cell therapies
- Non-CAR T cell approaches, including TILs and TCRs
- Alternative immune cell therapies, such as with NK cells, B cells, and macrophages
- Novel technologies for translational cellular therapies
It is anticipated that the efforts of this workshop will fuel innovative collaborative efforts as well as the dissemination of knowledge throughout the field.
This evening program features two sessions. The first session will open with an overview of the grant submission process, briefly outlining funding opportunities and how to navigate those. Session one will also address critical points of government and private sector grant submissions. The second session will consist of a “mini-study section,” allowing attendees to experience how a study section evaluates a grant proposal, which will help attendees identify points that determine the success or failure of a grant proposal and help them optimize the process of grant re-submission.